Catalyst Pharmaceuticals Inc (CPRX) — Free Cash Flow Generation Index
Catalyst Pharmaceuticals Inc (CPRX) has a Free Cash Flow Generation Index of 1.00x as of March 2026. Free cash flow of $59.56 Million represents 1% of operating cash flow ($59.59 Million). Read debt load of Catalyst Pharmaceuticals Inc for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Catalyst Pharmaceuticals Inc Free Cash Flow Generation Index (2019–2025)
Historical FCF Generation Index trend for Catalyst Pharmaceuticals Inc across 7 annual periods. Explore capital reinvestment ratio of Catalyst Pharmaceuticals Inc to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Catalyst Pharmaceuticals Inc (2019–2025)
Year-by-year Free Cash Flow Generation Index for Catalyst Pharmaceuticals Inc. For the full company profile including market capitalisation, see market value of Catalyst Pharmaceuticals Inc.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.00x | $208.61 Million | $208.67 Million | $58.00K | ▲ +0.2% |
| 2024 | 1.00x | $239.25 Million | $239.81 Million | $556.00K | ▲ +131.6% |
| 2023 | 0.43x | $61.86 Million | $143.60 Million | $81.74 Million | ▼ -56.9% |
| 2022 | 1.00x | $116.02 Million | $116.05 Million | $29.00K | ▲ +1.7% |
| 2021 | 0.98x | $59.35 Million | $60.37 Million | $1.02 Million | ▼ -1.7% |
| 2020 | 1.00x | $45.02 Million | $45.03 Million | $11.39K | ▲ +0.0% |
| 2019 | 1.00x | $34.59 Million | $34.61 Million | $19.37K | — |